REDWOOD CITY, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY) today announced that it will present a corporate overview at the JP Morgan 25th Annual Healthcare Conference in San Francisco. The presentation will be delivered on Thursday, January 11, 2007 at 8:30 a.m. (PST). A live webcast of the presentation can be accessed by visiting the investor relations section of the Company's website at www.maxygen.com. The webcast will be archived for 90 days.

About Maxygen

Maxygen Inc., headquartered in Redwood City, California, is committed to the discovery, development and commercialization of improved, next-generation protein pharmaceuticals for the treatment of human disease and serious medical conditions. For additional information on Maxygen, including access to Maxygen's SEC filings, please visit Maxygen's website at www.maxygen.com. Maxygen, Molecular Breeding, and the Maxygen logo are trademarks of Maxygen, Inc.

SOURCE Maxygen, Inc.